These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34398818)

  • 1. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
    Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH
    Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level.
    de Freitas VL; da Silva SC; Sartori AM; Bezerra RC; Westphalen EV; Molina TD; Teixeira AR; Ibrahim KY; Shikanai-Yasuda MA
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1277. PubMed ID: 21912712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
    Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
    Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A;
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.
    Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches.
    Flores-Chavez MD; Abras A; Ballart C; Ibáñez-Perez I; Perez-Gordillo P; Gállego M; Muñoz C; Moure Z; Sulleiro E; Nieto J; García Diez E; Simón L; Cruz I; Picado A
    Microbiol Spectr; 2022 Oct; 10(5):e0262822. PubMed ID: 36190410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
    Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
    Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil.
    Rodrigues-Dos-Santos Í; Melo MF; de Castro L; Hasslocher-Moreno AM; do Brasil PEAA; Silvestre de Sousa A; Britto C; Moreira OC
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006939. PubMed ID: 30418976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasite load evaluation by qPCR and blood culture in Chagas disease and HIV co-infected patients under antiretroviral therapy.
    Marcon GEB; Ferreira JJG; de Almeida EA; Delicio AM; Pereira MB; Wanderley JDS; Martins LC; Andrade PD; de Lima RG; Costa SCB
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010317. PubMed ID: 35353834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients.
    Sartori AM; Neto JE; Nunes EV; Braz LM; Caiaffa-Filho HH; Oliveira Oda C; Neto VA; Shikanai-Yasuda MA
    J Infect Dis; 2002 Sep; 186(6):872-5. PubMed ID: 12198628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions".
    Shikanai-Yasuda MA; Mediano MFF; Novaes CTG; Sousa AS; Sartori AMC; Santana RC; Correia D; Castro CN; Severo MMDS; Hasslocher-Moreno AM; Fernandez ML; Salvador F; Pinazo MJ; Bolella VR; Furtado PC; Corti M; Neves Pinto AY; Fica A; Molina I; Gascon J; Viñas PA; Cortez-Escalante J; Ramos AN; Almeida EA
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009809. PubMed ID: 34591866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation.
    Besuschio SA; Picado A; Muñoz-Calderón A; Wehrendt DP; Fernández M; Benatar A; Diaz-Bello Z; Irurtia C; Cruz I; Ndung'u JM; Cafferata ML; Montenegro G; Sosa Estani S; Lucero RH; Alarcón de Noya B; Longhi SA; Schijman AG
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008402. PubMed ID: 32797041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Trypanosoma cruzi/HIV coinfection in southern Brazil.
    Stauffert D; Silveira MF; Mesenburg MA; Manta AB; Dutra AD; Bicca GL; Villela MM
    Braz J Infect Dis; 2017; 21(2):180-184. PubMed ID: 27914221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Chagas disease: Quantification of Trypanosoma cruzi in peripheral blood and dejections of Triatoma infestans fed by xenodiagnosis in patients with and without cardiopathy.
    Apt W; Carrasco D; Fuentealba C; Canals M; Muñoz G; Saavedra M; Castillo JP; Zulantay I
    Acta Trop; 2019 Dec; 200():105167. PubMed ID: 31513762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
    Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V
    Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative PCR and unconventional serological methods to evaluate clomipramine treatment effectiveness in experimental Trypanosoma cruzi infection.
    Bazán PC; Lo Presti MS; Strauss M; Báez AL; Miler N; Paglini PA; Rivarola HW
    Exp Mol Pathol; 2016 Oct; 101(2):274-280. PubMed ID: 27677396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
    Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
    Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
    dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
    Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease.
    Parrado R; Ramirez JC; de la Barra A; Alonso-Vega C; Juiz N; Ortiz L; Illanes D; Torrico F; Gascon J; Alves F; Flevaud L; Garcia L; Schijman AG; Ribeiro I
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia.
    Vásquez Velásquez C; Russomando G; Espínola EE; Sanchez Z; Mochizuki K; Roca Y; Revollo J; Guzman A; Quiroga B; Rios Morgan S; Vargas Ortiz R; Zambrana Ortega A; Espinoza E; Nishizawa JE; Kamel MG; Kikuchi M; Mizukami S; Na-Bangchang K; Tien Huy N; Hirayama K
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007715. PubMed ID: 31553732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.